|Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.||
Examining the Link Between Price Regulation, Reimportation, and Pharmaceutical R&D Investment
This paper examines the link between prices and investment, and considers re-importation as another mechanism to control pharmaceutical prices. Vernon finds that if the U.S. imposed price controls on drugs it would lead to a 23% to 33% decline in industry R&D. Vernon's findings suggest that drug importation, far from being harmless, would slow the advancement of the next generation of critical medicines.
|home spotlight commentary research events news about contact links archives|